THERAPLAS

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Mar 2023 filing date already counts against anyone who files later.

Record

Serial number

97828627

Mark type

Stylized text

Filed

08 Mar 2023

Published for opposition

04 Mar 2025

Attorney of record

Monica Riva Talley

Goods and services

• Class 042 — Scientific and technological services: Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology

Owner

• Imunon, Inc., Lawrenceville, NJ, US
• Imunon, Inc., Lawrenceville, NJ, US

Prosecution history

• 29 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
• 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 04 Mar 2025 — PUBLISHED FOR OPPOSITION
• 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 11 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 24 Jan 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 22 Apr 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 22 Apr 2024 — LETTER OF SUSPENSION E-MAILED
• 22 Apr 2024 — SUSPENSION LETTER WRITTEN
• 13 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 13 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 13 Mar 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 13 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 13 Dec 2023 — NON-FINAL ACTION E-MAILED